675 WEST KENDALL STREET, CAMBRIDGE, MA
Reports First Quarter 2026 Financial Results and Highlights Recent Period Progress
Annual Report to Security Holders
CEO Appointment - Yvonne Greenstreet Named Chief Executive Officer
Financial Results, Press Release
Launches “Alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact
Announces Partial Repurchase of 1.00% Convertible Senior Notes Due 2027
Announces Changes to Board of Directors
Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress
FY 2024
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
Submission Upload
Correspondence